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Low-level carbon monoxide exposure
affects BOLD fMRI response
Caroline Bendell1, Shakeeb H Moosavi1 and
Mari Herigstad2
Abstract
Blood oxygen level dependent (BOLD) fMRI is a common technique for measuring brain activation that could be affected
by low-level carbon monoxide (CO) exposure from, e.g. smoking. This study aimed to probe the vulnerability of BOLD
fMRI to CO and determine whether it may constitute a significant neuroimaging confound. Low-level (6 ppm exhaled)
CO effects on BOLD response were assessed in 12 healthy never-smokers on two separate experimental days (CO and
air control). fMRI tasks were breath-holds (hypercapnia), visual stimulation and fingertapping. BOLD fMRI response was
lower during breath holds, visual stimulation and fingertapping in the CO protocol compared to the air control protocol.
Behavioural and physiological measures remained unchanged. We conclude that BOLD fMRI might be vulnerable to
changes in baseline CO, and suggest exercising caution when imaging populations exposed to elevated CO levels.
Further work is required to fully elucidate the impact on CO on fMRI and its underlying mechanisms.
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Introduction
One of the most common methods used to measure
brain function in humans is fMRI, of which blood
oxygen level dependent (BOLD) fMRI is arguably
the most mainstream technique. BOLD fMRI is an
indirect measure of brain activation, based on changes
in the ratio of oxygenated to deoxygenated blood in the
brain, which depends on cerebral metabolic rate
(CMRO2), cerebral blood volume (CBV) and cerebral
blood flow (CBF).1 These factors may be altered as
part of the experimental design or as unintended con-
founds, potentially affecting BOLD response.
Carbon monoxide (CO) is a toxic gas that can act
as a cerebral vasodilator.2,3 Increases in CBF with ele-
vations in CO have been shown in animal models3–7 as
well as in humans.8,9 Low-level CO exposure is
common, through inhalation of cigarette smoke or air
pollution. Due to its high affinity for haemoglobin, CO
immediately enters and can linger in the bloodstream
for several hours after inhalation. Smokers typically
have persisting elevated levels of CO bound to haemo-
globin in their blood (carboxyhaemoglobin, COHb),
which is reflected in higher exhaled levels of CO
(6 ppm in exhaled air or above10) compared to
non-smokers (1–5 ppm). As smoking behaviour is asso-
ciated with, e.g., socioeconomic status and disease
status, elevated COHb may significantly influence
neuroimaging results on the group level in certain
demographic groups. For example, if low-level CO
causes a baseline increase in CBF, this might affect
fMRI outcome as the BOLD response for any given
task is assessed by comparing task-related signal to
baseline signal. An increased baseline could artificially
dampen or alter the time course of the observed task-
specific BOLD response.11–13 To our knowledge, the
effect of CO on fMRI signal has not been investigated
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in previous studies, except as part of cigarette smoking,
where its impact is confounded by other (vasoactive)
tobacco components. The rationale for this study was
to test if CO could alter BOLD fMRI response in
response to three different fMRI tasks.
One method to test cerebral vascular function is
carbon dioxide (CO2) exposure. Hypercapnia induces
a strong CBF increase,14 and has often been used as a
cerebrovascular challenge in fMRI studies11,15–17 due
to its global and reproducible effect on BOLD
response.16,18 Raising baseline CBF by CO2 inhalation
can furthermore reduce or cause delays or non-linearity
in the vascular responsiveness to subsequent hypercap-
nia.11,12 In this study, we therefore used hypercapnia
derived through breath holds as a tool to investigate
the effect of CO on BOLD response, as it is a robust,
reproducible stimulus, and susceptible to changes in
baseline CBF. We hypothesised that low-level CO
inhalation would significantly reduce global BOLD
response during hypercapnia. To determine whether
the effect of CO extended to common fMRI para-
digms, we also included a simple visual stimulation
and motor task, hypothesising that CO would
dampen BOLD response in brain regions associated
with these tasks.
Materials and methods
Participants
We recruited 12 (8 F, age 25.3 4.3 years) healthy
never-smokers to the study. Never-smokers were
chosen to ensure a uniform sample group as smokers
typically have varying levels of COHb and may exhibit
variation in, e.g., craving. Exclusion criteria were
MRI contraindications, smoking history, history of
cardiorespiratory or neurological disease, and
pregnancy. Female participants were on hormonal con-
traceptives. All participants gave written, informed
consent. The study was approved by Oxford Brookes
University Research Ethics Committee (approval
number 140840) and carried out in accordance with
the Declaration of Helsinki. The sample size was deter-
mined by a formal statistical power calculation
(fMRIpower software package, www.fmripower.
org19). At alpha level 0.05, 11 subjects were found to
provide at least 80% power to detect an effect. Twelve
were recruited to ensure that the study was powered in
case of any unforeseen events (e.g. subject dropout).
Protocol
Participants were asked to attend a preliminary labo-
ratory visit. During this visit, medical history and state
and trait anxiety inventory (STAI) questionnaires were
completed.20 A CO inhalation test was conducted to let
the participant familiarise themselves with the breath-
ing system and the CO exposure. Participants were
asked to breathe on a custom-made breathing system
through a mouthpiece with their nose occluded, and
were given time for their breathing to stabilise before
commencing the experiment. A full description of
the breathing system can be found in the supplement.
After stable breathing had been recorded for 5 min,
CO was added to the inspired air over 5 min, out of
sight of the participant. Following CO administration,
five more minutes of stable breathing was recorded.
During the experiment, ECG, pulse pressure and satu-
ration were continuously measured. Expired CO was
measured before, immediately after, and 10min after
the breathing test (Microþ Smokelyzer, Intermedical
Ltd, Kent). The Smokelyzer kit is suitable for non-
invasive, repeated assessments of expired CO in
humans, and its output was compared with COHb
values (blood samples) prior to the study to ensure cor-
rect readings.
MRI scans were conducted on two separate days
(Figure 1). Participants were asked to complete the
state anxiety part of STAI on arrival and no more
than 15min after the end of the experiment on each
day. Whilst in the scanner, participants were asked to
undertake the following tasks: breath holds, a visual
stimulation task, a motor task and a simple reaction
time task. Breath holds were conducted end-expiration,
signalled by visual cues and lasting 15 s. Participants
were instructed to follow each breath-hold with an
expiration (rather than inspiration) to obtain accurate
end-tidal PCO2 values. The visual stimulation was a
Figure 1. Schematic of protocol. fMRI tasks included breath holds (T1), visual stimulation (8Hz flashing checkerboard, T2) and a
(right hand) finger tapping task (T3). Two sets of BOLD scans (each 10min 6 s) were obtained on each experimental day, separated by
a 5min breathing intervention (air or CO, order randomized and counterbalanced) during which a structural scan was acquired.
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flashing checkerboard (8Hz, lasting 10 s). The motor
task was tapping of the right index finger, signalled
by visual cues and lasted 15 s. The reaction time task
required participants to immediately press a button
upon the appearance of a red dot on the screen
(24 appearances, random intervals). These tasks were
conducted twice, once before the breathing interven-
tion (baseline) and once after (post-intervention). The
participants received the gas mixtures in the scanner,
and their head was kept in the same position for the
intervention and subsequent scan. On one day, the
intervention was air, and on the other day, the inter-
vention was CO. Participants were not aware of which
intervention would be given on any of the days and
the order of the interventions was randomised and bal-
anced. Participants were asked verbally after each pro-
tocol if they felt any change in their breathing, and if
they could guess which protocol they had undertaken.
Training in all fMRI tasks was given by an experiment-
er prior to the first scan on each day, to ensure that the
participant could reliably complete these on their own
in the scanner. Expired CO measurements were made
before the first scan, immediately after the second scan
(20min after the breathing intervention) and 10min
after the second scan (30min after the breathing
intervention). An extended protocol section can be
found in the supplement.
MRI data acquisition
Imaging was performed at the University of Oxford
Centre for Clinical Magnetic Resonance Research
with a Siemens 3 Tesla TIM-Trio scanner, using a
12-channel head coil. Participants were given two
fMRI scans (BOLD echo-planar image acquisition,
time repetition (TR)¼ 3000ms, time echo (TE)¼
30ms, field-of-view¼ 192 192mm, voxel-size¼ 3
33mm, 45 slices) on each day, separated by the inter-
vention period (air or CO). A structural T1-weighted,
whole-brain scan (MPRAGE, TR¼ 2040ms, TE¼
4.7ms, flip angle¼ 8, voxel-size¼ 1 11 mm) was
collected and used for image registration.
Heart rate (HR) and pulse oximetry (SaO2, multigas
monitor, 9500, MR Equipment), ECG, respiration
(respiratory bellows around the chest) and end-tidal
partial pressures of oxygen (PETO2) and CO2
(PETCO2; Datex, Normocap) were continuously mea-
sured throughout the scans. ECG data were observed
throughout. All physiological data were sampled at
50Hz and recorded along with scan volume triggers
via PowerLab 16/35 using LabChart (ADinstruments).
Data analysis
fMRI data processing was carried out within FSL
(Oxford Centre for Functional Magnetic Resonance
Imaging of the Brain (FMRIB) Software Library),
using FEAT (FMRI Expert Analysis Tool) Version
6.0. The cluster Z threshold was set to 3.1 and a cor-
rected cluster significance threshold to p¼ 0.05.
Prestatistic processing of the data included
MCFLIRT motion correction,21 spatial smoothing
with a full-width-half-maximum Gaussian kernel of
5mm and high-pass temporal filtering (Gaussian-
weighted least-squares straight line fitting, high-pass
filter cut-off of 60 s). FSL motion outliers (https://fsl.
fmrib.ox.ac.uk/fsl/fslwiki/FSLMotionOutliers) were
used to detect and regress out large motion artifacts.
Data were modelled using FMRIB’s Improved Linear
Model (FILM) with local autocorrelation correction.22
Images were registered to the MNI152 standard space
using an affine registration between the EPI and
T1-weighted scan and a nonlinear registration between
the T1-weighted scan and the MNI standard brain.
General linear models (GLMs) with multiple explan-
atory variables (EVs) incorporating timing values for
the different events were designed to describe the data.
The haemodynamic response function (HRF) was
modelled using a standard gamma waveform. A phys-
iological noise modelling tool was used to regress out
the effects of physiological noise.23 A 6-s haemody-
namic delay was assumed and contrast images were
used for higher level analyses as appropriate. An end-
tidal CO2 regressor was used to analyse the BOLD
response change associated with the breath-hold chal-
lenge. This was done by extracting the breath by breath
PETCO2 data and convolving this with an HRF (e.g.
see Bright and Murphy24). This approach models the
breath hold challenge response with the recorded
PETCO2 values and thus makes no assumption about
breath hold length. This analysis fits the signal to the
PETCO2 data and returns statistical maps of significant
changes in BOLD response (thresholded zstats). These
statistical maps were also converted to %BOLD/
mmHg CO2 in a second, separate analysis of cerebro-
vascular reactivity (CVR).
A fixed-effects model was used to generate contrast
of parameter estimate (COPE) images of the mean
signal for all scans as well as the difference between
the baseline and post-intervention scans for each par-
ticipant on each experimental day. The baseline versus
post-intervention difference COPE images were calcu-
lated to compensate for any variation in baseline
between days and account for potential test–retest
variability. This was done by forcing random effects
variance to zero in FLAME (FMRIB’s Local
Analysis of Mixed Effects).25,26
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Voxelwise statistical analysis was extended to a
group level, in a mixed-effects analysis using
FLAME26 with automatic outlier de-weighting, and Z
statistic images were thresholded using clusters deter-
mined by Z> 3.1 and a p< 0.05 (corrected) cluster sig-
nificance threshold. Means of COPE images were
calculated for all conditions. Group analyses compared
COPE images between protocols for each task using a
whole-brain approach, and with the following con-
trasts of interest: PETCO2 values with breath holds,
presentation of flashing checkerboards (visual task)
and finger-tapping. An analysis using the older stan-
dard of a 2.3 cluster-forming threshold was also con-
ducted, and is included in the Supplement.
STAI questionnaires were scored according to their
respective manuals and compared using paired non-
parametric t-tests (Mann–Whitney U test). Reaction
times were averaged for each participant and compared
using Student’s t-test (paired). Physiological data were
analysed using custom-written MATLAB scripts and
compared using Student’s t-tests (paired). Data
obtained during the motor task were used for the com-
parison of end-tidal gases between protocols.
Results
Psychological and physiological data
There were no significant differences between protocols
in anxiety scores (t(11)¼0.61, p¼ 0.55) or reaction
times (t(23)¼1.1, p¼ 0.29). None of the participants
was able to discern between CO and air inhalations,
nor did they report any change in breathing. PETO2
was reduced between baseline and post-intervention
scans in both protocols, but no significant difference
was found between protocols (t(11)¼0.58, p¼ 0.57).
There was no change in PETCO2 or HR between scans
or protocols. CO values increased significantly in the
CO protocol (p< 0.0001, Figure 2), but not air
(p¼ 0.10). COHb values (estimated from exhaled CO)
also showed a significant increase in the CO protocol
(p< 0.0001, Table 2), but not air. The modest rise in
COHb (from 1.1% 0.1 to 1.5% 0.2) highlights the
low level of CO used in the study. Participant details
are shown in Table 1, and physiological data in
Table 2. Extended participant demographics and phys-
iological data, including PETCO2 and PETO2 averages
and CO2 traces for all tasks, can be found in the
supplement.
fMRI data
For fMRI results, significance denotes thresholded,
cluster corrected, signal (cluster-forming threshold of
3.1, p< 0.05).27
Breath hold task (Figure 3). The rise in CO2 with breath
holds caused BOLD response change (increase)
throughout the grey matter during all scans. Figure 3
shows pre-intervention and post-intervention BOLD
response for both air and CO protocols, and group
(protocol) contrasts between the pre- versus post-
intervention difference maps. These Z score maps
Figure 2. Exhaled CO (ppm). Baseline, post-scan (20min
after end-inhalation) and 10min post-scan (30min after
end-intervention). Individual values plus average and standard
deviation (bold line).
Table 1. Participant details and behavioural data.
Preliminary visit MRI visit (CO) MRI visit (air)
Sex (F/M) 8/4 8/4 8/4
Age (years) 25.3 (4.3) 25.3 (4.3) 25.3 (4.3)
BMI (kg/m2) 23.6 (3.0) 23.6 (3.0) 23.6 (3.0)
Trait anxiety score 35.4 (7.2) [23–47] N/A N/A
State anxiety score 31.1 (8.6) [21–55] 27.0 (4.3) [21–35] 28.2 (4.4) [23–37]
RT change (post> pre) N/A 15.2 (24.3) 10.0 (21.8)
Note: Mean(SD). Range included for STAI scores.
BMI: body mass index; RT: reaction time.
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indicate a significant linear regression of the end-tidal
CO2 and BOLD response, as expected with rises in
PETCO2. This was seen for the control protocol and
the baseline scan (pre) for the CO protocol, but not
after CO inhalation. Following CO inhalation, activa-
tion was significantly reduced in the left insula, premo-
tor cortex, left secondary somatosensory cortex and in
the brain stem (see Supplement Figure S6). Group
comparisons showed lower significant BOLD response
change in the CO protocol compared to air in the left
operculum and insula.
CVR maps for the breath hold task can be found in
the supplement (Figure S5). Statistical comparisons
showed no difference in mean %BOLD/mmHg
between baseline (pre-intervention) scans, but a statis-
tically significant difference in post-intervention scans
(CVR lower in the CO protocol, p¼ 0.048).
Visual task (Figure 4). The flashing checkerboard gener-
ated significant BOLD activation in the visual cortex
for all scans. Group comparisons showed lower activa-
tion in response to the task in the CO protocol com-
pared to air. This was observed in the visual cortex.
Motor task (Figure 5). The finger-tapping task generated
significant task-related BOLD activation in the left pri-
mary and secondary somatosensory cortices, the left
premotor and primary motor cortices, the left thalamus
and the visual cortex for all scans. Group comparisons
showed lower activation in response to the task in the
CO protocol compared to air in the visual cortex. The
group analysis at a lower cluster-forming threshold
also showed higher activation in the CO protocol com-
pared to air in the premotor cortex (Figure S10).
Discussion
Key findings
In this study, we show that a small amount of inhaled
CO, raising expired levels from 3ppm to 6 ppm,
significantly alters BOLD response in never-smokers.
Figure 3. BOLD fMRI response associated with breath-by-
breath end-tidal CO2 during the breath hold task. Whole-brain
analysis. Images are colour-rendered statistical maps (Z scores)
superimposed on a standard (MNI) brain. Significant regions are
displayed with a threshold of Z> 3.1 with a cluster probability
threshold of p< 0.05 (corrected for multiple comparisons). Maps
are BOLD response associated with air and CO inhalation (pre-
and post-intervention), pre versus post-intervention difference
maps for each protocol (D), and contrasts between protocols
(contrast between the pre- vs. post-intervention difference
maps). For contrasts, blue-lightblue indicates where BOLD
response following CO (i.e. CO(post>pre)) was lower than
BOLD response following air – i.e. on the day the participants
inhaled CO, the BOLD response was reduced in the post-inha-
lation scan, but this did not occur on the day the participants
inhaled air. This difference between protocols was significant. In
no area was BOLD response following CO increased compared
to BOLD response following Air. A shows areas where change in
BOLD fMRI response for the CO protocol correlates with
individual rise in CO level. Red-yellow indicates a positive
correlation.
Table 2. Physiological data.
MRI visit (CO) MRI visit (Air)
Baseline Post-intervention Baseline Post-intervention
PETCO2 (%) 5.5 (0.7) 5.5 (0.7) 5.3 (0.7) 5.4 (0.7)
PETO2 (%) 15.5 (1.2) 15.0 (0.9)* 15.5 (0.7) 14.9 (0.7)**
HR (bpm) 69.3 (12.5) 66.2 (8.3) 71.3 (15.0) 63.5 (8.2)
CO (ppm) 2.9 (1.0) 5.7 (0.7)*** 3.0 (0.7) 2.7 (0.8)
COHb (%) 1.1 (0.1) 1.5 (0.2)*** 1.1 (0.1) 1.1 (0.1)
Note: Mean(SD). PETCO2, PETO2 and HR obtained during visual stimulation task. CO obtained pre-MRI and post-MRI
(20–25min after CO delivery). Estimated COHb included. Paired t-tests within visit *p< .05, **p< .01, ***p< .0001.
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This suggests that CO, even in low doses, might be a
confound in BOLD fMRI. Systematic differences in
COHb between, e.g., a patient group consisting of a
greater proportion of smokers and a control group of
predominantly non-smokers could generate group dif-
ferences that are CO-related rather than associated
with the specific research outcome. This could affect
the results of clinical trials and patient-oriented neuro-
science research. Given that absolute measures of CBF
were not obtained in this study, the mechanism under-
lying the observed impact remains unknown (although
potential mechanisms are discussed below). Future
studies should incorporate flow measurements using
techniques such as arterial spin labelling to further elu-
cidate the effect of CO on BOLD fMRI.
Discussion of findings
Studies have shown that global baseline increases in
CBF can reduce or alter task-related BOLD response.
For example, Cohen et al.28 used experimentally
induced hypercapnia to reduce visual activation, and
Brown et al.29 showed that the cerebral vasodilator
acetazolamide can dampen motor activation.
Similarly, Halani et al.11 showed that BOLD response
could be modulated by changes in baseline CBF
(induced by hypercapnia) as this altered the time
course of cerebrovascular responses. Yet this effect
has not yet been linked to CO exposure.
To probe the vulnerability of the BOLD response to
COHb elevation, we employed a low-level increase in
inhaled CO, raising exhaled levels to the lowest associ-
ated with tobacco smoking. Using this minimal level,
we observed significant effects on BOLD response
Figure 5. BOLD fMRI response during motor task. Whole-
brain analysis. Images are colour-rendered statistical maps
superimposed on a standard (MNI) brain. Significant regions are
displayed with a threshold of Z> 3.1 with a cluster probability
threshold of p< 0.05 (corrected for multiple comparisons). Maps
are BOLD response associated with air and CO inhalation (pre-
and post-intervention), and contrasts between protocols (con-
trast between the pre- vs. post-intervention difference maps).
For contrasts, blue-lightblue indicates where the BOLD response
following CO (i.e. CO(post>pre)) was lower than the BOLD
response following air.
Figure 4. BOLD fMRI response during visual stimulus. Whole-
brain analysis. Images are colour-rendered statistical maps
superimposed on a standard (MNI) brain. Significant regions are
displayed with a threshold of Z> 3.1 with a cluster probability
threshold of p< 0.05 (corrected for multiple comparisons). Maps
are BOLD response associated with air and CO inhalation (pre-
and post-intervention), pre versus post-intervention difference
maps for each protocol (D), and contrasts between protocols
(contrast between the pre- vs. post-intervention difference
maps). For contrasts, blue-lightblue indicates where BOLD
response following CO (i.e. CO(post>pre)) was lower than
BOLD response following air – i.e. on the day the participants
inhaled CO, the BOLD response was reduced in the post-inha-
lation scan, but this did not occur on the day the participants
inhaled Air. This difference between protocols was significant.
In no area was (CO(post>pre)) greater than (Air(post>pre).
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during a hypercapnic challenge and during commonly
used visual and motor tasks. The large impact of low-
level CO exposure on common fMRI paradigms such
as a simple flashing checkerboard and finger-tapping
tasks highlights the relevance of the present findings.
The effect of CO on BOLD response was not uni-
form. BOLD response changes associated with visual
and motor tasks were impacted by CO exposure.
Compared to air, the BOLD response changes were
lower for the visual task and lower in the visual
cortex during the motor task, but analysis using a
lower cluster-forming threshold of 2.3 also showed an
area of activation in the motor cortex that was higher
compared to air during the motor task (see Figure S10).
The reduction in visual cortex signal mirrors that for
the visual task, and may be associated with the visual
instructions on screen throughout tapping intervals.
The agreement in CO-impact on BOLD response
in the visual cortex between these two separate and
different tasks is encouraging. However, the higher
BOLD response in the motor cortex after CO exposure
compared to after air, despite only surviving at a lower
cluster-forming threshold (Figure S10, S11), could indi-
cate that the impact of CO on global fMRI signal
might be complex. Studies have shown that hypercap-
nia may affect BOLD response differently depending
on the type of task and activated brain regions. For
example, Kastrup et al.30 reported that BOLD response
changes with hypercapnia were greater in the visual
cortex than in the sensorimotor cortex, possibly due
to the location of large veins and/or neural activity
associated with respiratory stimuli.31 Bright et al.12
have shown that there are regional differences in opti-
mal haemodynamic delay under hypercapnic condi-
tions, with the visual cortex trending towards lower
optimal delay than, e.g., the parietal lobe. It is possible
that the regional variations observed in our study is, in
part, due to variations in optimal haemodynamic delay
although further studies are required to fully elucidate
the underlying mechanism.
Potential mechanisms
At present, we cannot be certain of the mechanism(s)
underlying CO mediation of BOLD response. Acute
CO exposure can cause cerebral vasodilation both
directly32 and indirectly through nitric oxide,33 and
changes in CBF can impact BOLD response in a vari-
ety of ways.34 Increases in baseline CBF can create
ceiling effects, thus reducing task-related signal.34 For
example, hypercapnia has been shown to increase base-
line CBF, reduce BOLD activation28,34 and alter the
time course of the BOLD response11,12 in a potentially
region-specific manner.12 While it is difficult to draw
direct comparisons between hypercapnia and CO
exposure, particularly during breath holds as CO and
CO2 may interact,
35 it is possible that similar mecha-
nisms underlie our findings. Hypercapnia has also
been shown to reduce CVR13 (but see also12). Indeed,
we observed that CVR following CO inhalation was
significantly reduced compared to CVR following air
inhalation, suggesting that CO may affect BOLD
response at least partly through changes in CVR.
In summary, both alteration of the BOLD response
time course and changes in CVR may explain the
impact of CO on BOLD response in our study.
Other mechanisms that may contribute to the
observed BOLD response change include the formation
of COHb at the expense of oxyhaemoglobin. This may
cause increased CBF through the development of
hypoxia,36 and may be augmented by the presence of
hypercapnia.35 While we observed reduced PETO2
during the second scan on each experimental day, this
was similar for both protocols, and may thus rather be
due to altered breathing patterns during the experimen-
tal protocol despite pre-scan acclimatization to the
breathing system. Furthermore, PETO2 remained
within normal range throughout the experiment. It is
therefore unlikely that hypoxia is the cause of the
observed group differences. Hypoxia may, however,
contribute to BOLD response changes at higher doses
of CO. Another way in which CO could reduce BOLD
response is by shifting the oxygen dissociation curve to
the left, reducing oxygen availability. While this is
unlikely to be the mechanism in the present study,
given the low levels of COHb observed, the impact of
CO on physiology is complex and should not be
ignored.
CO may also slightly inhibit cell respiration even
under normoxic conditions37 and it remains unknown
whether the observed effect on BOLD response is
linked in part to metabolic modulation. Similarly, we
cannot rule out the possibility that CO altered BOLD
response through its role as an endogenous
neurotransmitter.38
Participants showed no change in reaction times
with CO compared to air, no difference in anxiety
scores, and were not able to tell which protocol they
were undertaking when prompted. It is thus unlikely
that the effect on BOLD response observed in our
study is driven by behavioural factors.
While further work is required to elucidate the pre-
cise mechanism underlying our findings, it is clear that
CO can alter BOLD response, and should be consid-
ered a non-negligible neuroimaging confound. Further
work should include formal comparisons between
smokers and non-smokers to determine the impact of
CO on BOLD response in a wider population beyond
our tightly-controlled sample.
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Brain regions
As the purpose of the study was to assess whether there
is an overall, global effect of CO on BOLD response
rather than interrogating specific neural responses,
tasks were not linked to behavioural measures.
Consequently, the following interpretation of BOLD
response change patterns is speculative in nature as it
relies upon reverse inference, and will be kept short.
We observed BOLD response reductions after CO for
the visual task in the visual cortex (as expected for this
task), although this was not found in the contrast
between protocols. The BOLD response change outside
of the visual cortex was not significant in either mean
analysis, suggesting that protocol differences were
driven by small variations in signal between protocols
(see e.g. Herigstad et al.39). Similarly, group analysis
showed reduced BOLD response change in response
to the breath hold task in the left insula, which is asso-
ciated with breathing challenges and anticipation of the
same.39–42 Mean contrasts also highlighted differences
in the premotor cortex, left secondary somatosensory
cortex, left supramarginal gyrus39,40 and in the brain
stem.40,43 The reason for the lateralisation remains
unknown, but may be due to left-lateralisation associ-
ated with reading.44 It is thus possible that there are
effects of CO on BOLD response that are specific to
respiratory processing centres, and that tasks probing
such regions could be particularly susceptible to CO
effects, although further studies incorporating appro-
priate behavioural measures are required to determine
if this is the case.
Implications for neuroimaging and clinical trials
In this study, we show that low-level CO exposure may
significantly alter BOLD response. Due to its affinity
for haemoglobin, CO is not readily removed and there-
fore its effects on signal could persist for some time
following inhalation. Here, CO assessments made fol-
lowing the scan (approximately 20 and 30min after the
intervention) show steady, elevated levels of exhaled
CO (Figure 2). This level of CO exhalation is at the
lower end of that associated with smokers, with mean
exhaled values being more than 20 ppm in outpatient
groups.10 It remains unknown if higher levels of CO
exposure will have a greater effect (i.e. a dose-
dependent effect similar to that observed in rat
aortas45). Furthermore, the findings observed in this
paper suggest that the effect may be region- and/or
task-dependent, which could complicate any potential
adjustments for COHb during analysis.
Smoking is associated with a range of diseases,
including cardiorespiratory diseases, cancers, dementia
and cognitive decline46 and several mental disorders,47
as well as demographic factors such as socioeconomic
status, education and income level.48 CO exposure
through cigarette smoking could therefore constitute
a significant confound in neuroimaging research.
Differences in COHb may occur both longitudinally
(e.g. if smoking participants or patients are encouraged
to stop smoking) and whenever participants or patients
are compared with controls that are not precisely
matched for smoking behaviour. Furthermore, the pos-
sibility for dose-dependent effects means that it may
not be sufficient to match simply for ‘smoker’ and
‘non-smoker’, but rather the amount of COHb present
in the blood stream. Given that only a small increase
in COHb might affect BOLD response, this
confound should be monitored carefully, particularly
in clinical trials.
Conclusions
We conclude that even small amounts of inhaled CO
might significantly alter BOLD response during simple
tasks such as breath hold, visual stimulation and finger-
tapping. Further research is required to assess the
precise underlying mechanism of this effect as well as
generalisability to a wider population including smok-
ers. We suggest that care should be taken to include CO
as a potential confound in neuroimaging research when
appropriate, for example in studies on clinical popula-
tions with greater/lower prevalence of smokers.
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